WAM
AXDX

Wolverine Asset Management’s Accelerate Diagnostics AXDX Stock Holding History

Wolverine Asset Management’s Portfolio AXDX Stock Details AXDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-100
Closed -$171 – 1626
2024
Q3 		$171 Hold
100
– – ﹤0.01% 1606
2024
Q2 		$117 Hold
100
– – ﹤0.01% 1634
2024
Q1 		$99 Hold
100
– – ﹤0.01% 1628
2023
Q4 		$392 Buy
+100
New +$529 ﹤0.01% 1671
2022
Q3 		– Sell
-1,120
Closed -$11K – 2389
2022
Q2 		$11K Buy
1,120
+400
+56% +$3.53K ﹤0.01% 1956
2022
Q1 		$10K Buy
720
+340
+89% +$9.68K ﹤0.01% 1890
2021
Q4 		$19K Buy
+380
New +$21.2K ﹤0.01% 1724
2021
Q2 		– Sell
-5,940
Closed -$494K – 2162
2021
Q1 		$494K Sell
5,940
-1,390
-19% -$141K ﹤0.01% 914
2020
Q4 		$555K Buy
7,330
+4,940
+207% +$442K ﹤0.01% 814
2020
Q3 		$254K Buy
2,390
+880
+58% +$122K ﹤0.01% 916
2020
Q2 		$228K Buy
1,510
+1,000
+196% +$98.6K ﹤0.01% 891
2020
Q1 		$42K Buy
+510
New +$71.8K ﹤0.01% 1193
2019
Q4 		– Sell
-200
Closed -$37K – 1353
2019
Q3 		$37K Sell
200
-1,430
-88% -$276K ﹤0.01% 1243
2019
Q2 		$372K Sell
1,630
-7,980
-83% -$1.56M ﹤0.01% 914
2019
Q1 		$2.02M Buy
+9,610
New +$1.8M 0.03% 420
2018
Q4 		– Sell
-5,390
Closed -$1.24M – 1603
2018
Q3 		$1.24M Buy
5,390
+4,890
+978% +$1.08M 0.01% 732
2018
Q2 		$111K Hold
500
– – ﹤0.01% 1176
2018
Q1 		$114K Buy
+500
New +$131K ﹤0.01% 1210

Other funds holding AXDX

AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
GAM
Griffin Asset Management New York $949M AUM 24.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Birchview Capital Burlington, Vermont $214M AUM 185.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CS
Cannell & Spears New York $5.62B AUM 41.25% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BAM
Belpointe Asset Management Reno, Nevada $3.06B AUM 23.82% 1-Year Est. Return
TWA
TCI Wealth Advisors Tucson, Arizona $2.31B AUM 26.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Wolverine Asset Management's AXDX Position: Q2 2022 in Review

Wolverine Asset Management sold out of Accelerate Diagnostics (AXDX) in Q2 2022, closing a stake of 469 shares — an estimated $4.14K sold.

Wolverine Asset Management first reported a position in AXDX in Q1 2018 and held it in 5 quarters. The position peaked at $26K in Q1 2018. 74 funds tracked by Wall St. Rank hold AXDX as of Q2 2022.

  • Wolverine Asset Management reported no remaining Accelerate Diagnostics position as of Q2 2022 after selling out during the quarter.
  • Wolverine Asset Management sold 469 Accelerate Diagnostics shares in Q2 2022, an estimated $4.14K.
  • Wolverine Asset Management first reported a position in Accelerate Diagnostics in Q1 2018 and held it in 5 quarters.
  • Wolverine Asset Management's Accelerate Diagnostics position peaked at $26K in Q1 2018.
  • 74 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q2 2022.

Based on Wolverine Asset Management's 13F filing for Q2 2022, filed 3 Aug 2022.